295th Edition – March 13, 2018

You thought the Shark Tank was tough…

wait until you enter the the BioHealth Capital Region Crab Trap!

Submit your application for the opportunity to be named the company with the most commercial potential at the 2018 BioHealth Regional Forum, $10,000, and MORE!

Application Deadline: March, 30th 2018 

Finalists will be announced: April 9th, 2018 

Finalist Presentations BioHealth Capital Region Forum Event: April 24th, 2018

Submit an Application »

Read More

April 23-24  |  1 MedImmune Way, Gaithersburg MD 20878 

This invitation-only event is free for executive level biotech leaders and is presented by BioHealth Innovation, VirginiaBio, Inova, Children’s National Health System, QIAGEN, Maryland Tech Council, University System of Maryland and MedImmune/AstraZeneca. Maryland, Virginia, and Washington, DC set the bar high for biotech innovation. So please join us for our Annual BioHealth Capital Region Forum that will highlight the accomplishments of today and chart our successes of tomorrow.

We are excited to bring you an exceptional line up of speakers. The program will feature sessions that focus on the Advancing Science and Accelerating Innovation.

Read More

Have you drafted your application for the April 5th SBIR Funding application deadline?  For qualified companies, BioHealth Innovation, will provide an additional review and support.  If interested, email BHI@BIoHealthInnovation.org by this Friday, March 16th.

Read More

After a year of surging growth, Supernus Pharmaceuticals Inc. is building out a new home double its current size.

Read More

PointClickCare Technologies, the leading cloud-based software vendor for the long-term and post-acute care (LTPAC) market, announced today its strategic partnership with Redox Inc., the leading integration platform for healthcare data exchange. Together, PointClickCare and Redox will work to bridge the gap between the acute and post-acute markets, empowering health systems with the visibility required for a truly coordinated and collaborative approach to care delivery across the healthcare continuum.

Read More

Summer R.I.S.E. (Real Interesting Summer Experience) is a unique opportunity for Montgomery County youth to explore potential careers and for our local businesses to participate in developing a talent pipeline. The initiative is led by WorkSource Montgomery, Inc. (WSM), Montgomery County Public Schools (MCPS) and supported by county and state government partners, local businesses and non-profit organizations. Local businesses and governmental organizations volunteer to bring rising high school juniors and seniors into their workplaces to provide hands‐on, real world career experiences.

Read More

Will Your Company be the Buzz of BIO?

Are you an innovative biotech company that is R&D-intensive and looking to develop strategic partnerships within the industry? Nominate your company to be the Buzz of BIO!

Winners receive complimentary registration that includes BIO One-on-One Partnering™, a Company Presentation slot in the BIO Business Forum, and marketing promotion to thousands of industry leaders.

Nominations End March 16

Read More

The Centers for Medicare and Medicaid Services has announced a new initiative designed to provide patients access to their electronic health records and share their data with their preferred health care providers.

Read More

Rexahn Pharmaceuticals, Inc. (NYSE American:RNN), a clinical stage biopharmaceutical company developing innovative, targeted therapeutics for the treatment of cancer, today announced financial results for the year ended December 31, 2017.

Read More

Life science industry impacts N.J. economy in big way, C&W report says By Emily Bader New Jersey | Mar 7, 2018 at 11:44 am

The life science industry is fueling New Jersey’s economy through revenue and job growth, according to a report by Cushman & Wakefield.

Read More

Millions of travelers suffer from jet lag every year. And now Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) said one of its drugs successfully addressed the problem with hundreds of volunteers in a late-stage clinical trial.

Read More

Sonavex, Inc. announced today the final closure of its expanded $4.5M Series A and filing of a 510(k) submission to the U.S. Food and Drug Administration (FDA) for its EchoMark device. The proceeds will accelerate Sonavex’s commercial launch later this year and support further product development. Participants in the additional financing included Fusion Fund (aka NewGen Capital), FundRx, and existing investors.

Read More

TEDCO, Maryland’s economic engine for technology companies, inducts ClearMask into its mdPACE program to assist in bringing its life-changing innovation to market. Baltimore-based, ClearMask LLC is the developer of the country’s first, full-face transparent surgical mask designed to help healthcare entities reduce medical errors caused by miscommunication and provide a better experience for deaf patients and other patient groups who heavily rely on visual cues, including children, limited English proficiency patients, and immunosuppressed patients who cannot see the smiles of their loved ones and care team.

Read More

Symbiont Health, maker of innovative technology to detect falls for seniors and nursing home patients, took home the $15,000 grand prize at yesterday’s Pitch Dingman Competition, the University of Maryland’s business competition chaired by businessman and philanthropist Robert G. Hisaoka. The competition awarded nearly $30,000 in seed funding to top student entrepreneurs in a “Shark Tank”-style pitch session, hosted by the Dingman Center for Entrepreneurship at the Robert H. Smith School of Business.

Read More

23andMe, Inc., the leading personal genetics company, today received the first-ever FDA authorization for a direct-to-consumer genetic test for cancer risk. The authorization allows 23andMe to provide customers, without a prescription, information on three genetic variants found on the BRCA1 and BRCA2 genes known to be associated with higher risk for breast, ovarian and prostate cancer.

Read More

The Innovative Molecular Analysis Technology Development for Cancer Research and Clinical Care (SBIR-IMAT) solicitation is a companion SBIR funding opportunity announcement to the NCI Innovative Molecular Analysis Technologies (IMAT) Program aimed at the inception, development, integration, and application of novel and emerging technologies in support of cancer research, treatment, diagnosis, and prevention.

Read More

Surgeons trying a new way to save the life of a baby born with half a heart stood over her open chest and waited for the FedEx box.

Read More

Get answers from experienced entrepreneurs and legal/business professionals on how to build a successful startup company. Receive free and impartial advice, brainstorm business strategies, investigate funding opportunities and learn about the vast resources available to entrepreneurs.

Wednesday, March 14, 2018, 4-6 p.m.

TAP Building, 387 Technology Drive, Room 1105, UMD

Read More

The dispute is already underway. In August, the Trump administration initiated a sweeping investigation into Chinese trade practices, including whether Chinese firms are investing in U.S. companies to steal their technology and whether they are forcing joint ventures, pressuring American companies that invest in China to transfer technology to a Chinese partner, or hacking U.S. companies’ software.

Read More

Officials from Amazon.com toured sites in Washington, Montgomery County, Md., and Northern Virginia last week — the latest sign that the tech giant is seriously considering adding a second headquarters with as many as 50,000 jobs to the D.C. area, according to officials in all three jurisdictions.

Read More

A team of students from Virginia Tech claimed victory at the fourth annual Deloitte Foundation Cyber Threat Competition for their analysis and incident response approach to a simulated cyber event. Anirudh Bagde, Danny Colmenares, Nicholas Herman and Andy Wong, the school’s team members, each received $2,000 in scholarship money.

Read More

New compounds targeting epigenetics have shown remarkable early activity in patients with lymphoma, according to data presented at the TAT (Targeted Anticancer Therapies) International Congress 2018 in Paris, France. ESMO’s phase-I oncology meeting featured early clinical studies with BET inhibitors and EZH2 inhibitors.

Read More

Join ISPE Chesapeake Bay Area Chapter, Maryland Tech Council, BioHealth Innovation and ByteGrid for a one day Life Sciences Cloud & Infrastructure Conference.

Listen to speakers, including Krishna Ghosh, Ph. D., Senior Policy Advisor at the Food and Drug Administration, and the co-chairs of the GAMP Cloud Special Interest Group and get a behind-the-scenes data center tour of ByteGrid’s flagship Silver Spring facility.

You’ll also get valuable insights into cloud adoption in the regulated Life Sciences industry, hear about updates to the revised ISPE GAMP Good Practice Guide on IT Infrastructure and much more!

The agenda and speakers are listed here: https://hubs.ly/H0b3TKs0

Read More

Join BioBuzz and founding sponsor The Johns Hopkins University Montgomery County Campus at Bar Louie on March 14th. The Johns Hopkins University Montgomery County Campus offers part-time graduate courses in biotechnology fields. Students attend classes in the evenings and on Saturdays, enabling them to hold full-time jobs during the day. Depending on the degree area, students can fully complete their coursework in Montgomery County. Other students take some courses in Baltimore and/ or online.

Read More